GlassScriptPhysician profile
Victoria Lasala
NPI 1346858958
$19,349.66
in general payments reported to CMS, 2019-2025
28 companies · $6,103 in 2025
The $6,103 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $989 · 2022: $2,697 · 2023: $3,196 · 2024: $6,364 · 2025: $6,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,803 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $986 · Education: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,344.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,803.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $985.50 |
| Education | $530.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $4,276.40 | 2021-2025 | Ilumya, Absorica Ld, Winlevi |
| Janssen Biotech, INC. | $2,356.99 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Abbvie INC. | $2,197.76 | 2021-2025 | |
| Lilly USA, LLC | $1,214.44 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $1,136.81 | 2021-2025 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $1,008.31 | 2023-2025 | Zoryve |
| Incyte Corporation | $972.89 | 2021-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $830.35 | 2021-2025 | |
| Genzyme Corporation | $750.57 | 2021-2025 | |
| Galderma Laboratories, L.P. | $745.36 | 2021-2025 | Nemluvio, Aklief, Oracea |
| Pfizer INC. | $736.70 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $496.42 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $495.75 | 2022-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $454.93 | 2022-2025 | Dupixent, Libtayo |
| Dermavant Sciences, INC. | $350.87 | 2023-2024 | Vtama |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $333.28 | 2021-2025 | Cabtreo, Siliq, Duobrii |
| Amgen INC. | $263.33 | 2023-2025 | Otezla, Otezla |
| Almirall LLC | $198.51 | 2022-2025 | Klisyri |
| Organon LLC | $111.07 | 2025 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.28 | 2023-2025 | Spevigo |
| Verrica Pharmaceuticals INC. | $80.32 | 2023-2025 | Ycanth |
| Sanofi-Aventis U.S. LLC | $64.95 | 2021 | |
| Vyne Pharmaceuticals INC. | $54.71 | 2021 | |
| Coopersurgical, INC. | $36.97 | 2023 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Epi Health, LLC | $27.00 | 2022 | |
| Mayne Pharma Commercial LLC | $19.76 | 2022 | |
| Biofrontera INC. | $18.30 | 2022 | |
| Sebela Pharmaceuticals INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Lasala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.